Pulmatrix

PULMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.063 M

$1.66 +0.00%

Close of 7 Aug 2026

Revenue

$7.81M

#3217 by revenue

Earnings

-$5.16M

Loss-making

Shares outstanding

3,652,285

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#462HCW BiologicsHCWB$6.19M
#463NuCanaNCNA$6.12M
#464PulmatrixPULM$6.06M
#465GelteqGELS$5.98M
#466GeoVax LabsGOVX$5.67M

Where these numbers come from

Share counts and financials for Pulmatrix are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.